Annexin Pharmaceuticals AB (ANNX) — Net Asset Quality Index
Annexin Pharmaceuticals AB (ANNX) has a Net Asset Quality Index of 72.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr19.98 Million minus total liabilities of Skr5.56 Million yields net assets of Skr14.42 Million. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of Annexin Pharmaceuticals AB to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Annexin Pharmaceuticals AB Net Asset Quality Index Over Time (2014–2025)
This chart shows how Annexin Pharmaceuticals AB's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the index stands at 72.2%, representing net assets of Skr14.42 Million against total assets of Skr19.98 Million SEK. Explore Annexin Pharmaceuticals AB cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Annexin Pharmaceuticals AB (2014–2025)
The table below presents the year-by-year Net Asset Quality Index for Annexin Pharmaceuticals AB from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Annexin Pharmaceuticals AB (ANNX) market capitalisation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 82.7% | Skr24.93 Million | Skr30.16 Million | Skr5.22 Million | ▲ +10.6 pp |
| 2024 | 72.0% | Skr13.71 Million | Skr19.04 Million | Skr5.32 Million | ▲ +1.7 pp |
| 2023 | 70.3% | Skr18.81 Million | Skr26.76 Million | Skr7.95 Million | ▼ -11.9 pp |
| 2022 | 82.2% | Skr30.15 Million | Skr36.68 Million | Skr6.53 Million | ▼ -6.3 pp |
| 2021 | 88.5% | Skr46.73 Million | Skr52.79 Million | Skr6.06 Million | ▲ +6.5 pp |
| 2020 | 82.0% | Skr20.64 Million | Skr25.16 Million | Skr4.52 Million | ▲ +10.4 pp |
| 2019 | 71.6% | Skr11.49 Million | Skr16.04 Million | Skr4.55 Million | ▼ -14.9 pp |
| 2018 | 86.6% | Skr39.85 Million | Skr46.04 Million | Skr6.19 Million | ▲ +7.3 pp |
| 2017 | 79.2% | Skr24.44 Million | Skr30.85 Million | Skr6.41 Million | ▲ +12.8 pp |
| 2016 | 66.4% | Skr15.57 Million | Skr23.46 Million | Skr7.88 Million | ▲ +70.7 pp |
| 2015 | -4.4% | Skr-137.00K | Skr3.15 Million | Skr3.28 Million | ▼ -77.8 pp |
| 2014 | 73.4% | Skr2.71 Million | Skr3.69 Million | Skr981.14K | — |